Submission Preparation ChecklistAs part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
- The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
- Where available, URLs for the references have been provided.
- The text is single-spaced; uses a 12-point font; employs italics for foreign phrases, and bold for emphasis rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
- If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
- If the article will be accepted for publication, the Authors will sign and send to the Publisher the Publication Agreement (downloadable here)
- The Authors will also sign and send to the Publisher the Declaration of Financial Competing Interests (downloadable here)
Editorials are short articles on issues of topical importance. We encourage our editorial writers to express their opinions, giving the author the opportunity to present criticism or address controversy. The intention is very much that the article should offer a personal perspective on a topic of recent interest.
(Figures and tables can be included in editorials, if necessary).Word limit: about 1,000-1,500 words
Narrative reviewsNarrative reviews address a specific question or issue that is relevant for clinical practice and provide an evidence-based, balanced, patient-oriented review on a focused topic. Narrative reviews should include the clinical question or issue and its importance for general medical practice, speciality practice, or public health; description of how the relevant evidence was identified, assessed for quality, and selected for inclusion; synthesis of the available evidence such that the best-quality evidence (e.g., well-conducted clinical trials, meta-analyses, and prospective cohort studies) should receive the greatest emphasis; and discussion of controversial aspects and unresolved issues. The text is limited to about 6,000 words (not including abstract, tables, figures, and references); about 6 tables, and no reference limit. The review should include a box with “The review in brief ”, listing the key points of the review, and a box with “Questions for further research”.
Systematic reviews and meta-analyses are a particular type of original articles that perform systematic, critical assessment of literature and data sources pertaining to clinical topics, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention. All articles or data sources should be searched for and selected systematically for inclusion and critically evaluated, and the search and selection process should be described in detail in the manuscript. The specific type of study or analysis, population, intervention, exposure, and tests or outcomes should be described for each article or data source. A structured abstract of about 300-600 characters is required; for more information, see instructions below for preparing structured abstracts. The text is limited to 6,000 words (not including abstract, tables, figures, and references); about 6 tables (a flow diagram that depicts search and selection processes as well as evidence tables should be included), and there are no reference limits. The review should include a box with “The review in brief ”, listing the key points of the review, and a box with “Questions for further research”.
Meta-analyses also will be considered as reviews as long as they follow the instructions for systematic reviews. Authors of reports of meta-analyses of randomized trials are encouraged to follow the PRISMA guidelines (http://www.prisma-statement.org) and the QUORUM standards (http://www.consort-statement.org)
Letter to the EditorLetters discussing a recent article in the journal or an important or critical topic in the medical field
Copyright NoticeAuthors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)
Privacy Statementt is SEEd Srl’s policy to respect your privacy regarding any information we may collect while operating our websites. Owner of the processing of personal data is SEEd srl (Via Magenta, 35 - 10128 Turin, Italy).
In compliance with the General Data Protection Regulation (GDPR - EU 2016/679), we inform you that the names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal (online submissions, editorial workflow tracking, call for papers, online publication, and updates) and will not be made available for any other purpose or to any other party. Only with your optional consent, you will receive notices for the publication of new issues. You have the right, at any time and free of charge, to ask the data controller to access your personal data, correct or delete them and limit their processing. Furthermore, you have the right to restrict certain processing, to object to your personal data being processed for direct marketing purposes, to the portability of data and to propose a complaint to a supervisory authority.
For more information, please refer to the page http://www.seedmedicalpublishers.com/privacy-statement-cookies-policy/